Cancer Survival
News Pharmaceuticals

Cancer Survival Improvements Stall in UK, Experts Call for Policy Overhaul

UK has raised alarms about a concerning trend in cancer survival. The study reveals that progress in improving UK cancer survival rates has slowed significantly over the past decade. This stagnation comes despite major investments in cancer research, technology, and treatment access. The analysis, based on national cancer registry data, shows that while more people […]

zongertinib
News

FDA Approves Zongertinib, First Oral Drug for HER2+ NSCLC

New York, United States | August 14, 2025- The Food and Drug Administration granted accelerated approval to zongertinib (Hernexeos, Boehringer Ingelheim Pharmaceuticals, Inc.), a kinase inhibitor, for adults with unresectable or metastatic non-squamous non-small cell lung cancer (NSCLC) whose tumors have HER2 (ERBB2) tyrosine kinase domain (TKD) activating mutations, as detected by an FDA-approved test, […]